Latest Legal And Regulatory News

Bastion Mining has surpassed the critical 50.1% ownership threshold in Xanadu Mines, removing key conditions from its takeover bid and declaring the offer unconditional.

Renergen Limited reports steady LNG production despite maintenance downtime, progresses a strategic merger with ASP Isotopes, and advances exploration with new seismic data and drilling activity.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

IDM International shareholders have overwhelmingly approved Blackstone Minerals’ acquisition via a scheme of arrangement, setting the stage for a transformative merger in the copper-gold mining sector.

Classic Minerals Limited has issued a prospectus for a nominal share offer aimed at removing trading restrictions on placement shares issued to creditors, while navigating significant financial challenges and ongoing litigation over key tenements.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ notice attempting to terminate their merger agreement, setting the stage for a potential courtroom showdown over the disputed deal.

Ovanti Limited is set to raise approximately $1 million through a two-tranche share placement to support its US buy now, pay later expansion and ongoing legal matters.

South Africa’s Minister of Mineral Resources has upheld Renergen’s helium extraction rights at the Virginia Gas Project, rejecting an appeal from Springbok Solar and securing the company’s production future.

Yowie Group has lodged a formal application with the Takeovers Panel to block Keybridge Capital from convening a shareholder meeting aimed at replacing Yowie’s board, accusing Keybridge of trying to frustrate its takeover offer.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

Monash IVF Group has lowered its full-year profit guidance for FY2025 to $27.5 million, citing weaker market conditions and ongoing impacts from a recent operational incident in Brisbane. The company remains cautious as it monitors patient trends and legal costs.

Metgasco Ltd has announced a non-renounceable entitlement offer to raise approximately $0.75 million at a discounted price of 0.2 cents per share, aiming to fund production uplift programs and working capital. The offer is partially underwritten and includes a Top-Up Facility for eligible shareholders.